BR9916156A - Método e composição para a manutenção e restituição de integridade do intestino - Google Patents

Método e composição para a manutenção e restituição de integridade do intestino

Info

Publication number
BR9916156A
BR9916156A BR9916156-7A BR9916156A BR9916156A BR 9916156 A BR9916156 A BR 9916156A BR 9916156 A BR9916156 A BR 9916156A BR 9916156 A BR9916156 A BR 9916156A
Authority
BR
Brazil
Prior art keywords
maintaining
composition
integrity
intestinal integrity
restoring intestinal
Prior art date
Application number
BR9916156-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Susan Marie Kaup
Michael Scott Caplan
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9916156A publication Critical patent/BR9916156A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR9916156-7A 1998-12-15 1999-12-13 Método e composição para a manutenção e restituição de integridade do intestino BR9916156A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11237498P 1998-12-15 1998-12-15
PCT/US1999/029478 WO2000035443A1 (en) 1998-12-15 1999-12-13 Method and composition for the maintenance and restitution of gut integrity

Publications (1)

Publication Number Publication Date
BR9916156A true BR9916156A (pt) 2001-09-04

Family

ID=22343574

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916156-7A BR9916156A (pt) 1998-12-15 1999-12-13 Método e composição para a manutenção e restituição de integridade do intestino

Country Status (14)

Country Link
EP (1) EP1140063A1 (es)
JP (1) JP2002532420A (es)
KR (1) KR20020002361A (es)
CN (1) CN1330542A (es)
AR (1) AR021669A1 (es)
AU (1) AU3119600A (es)
BR (1) BR9916156A (es)
CA (1) CA2351469A1 (es)
EA (1) EA200100662A1 (es)
HU (1) HUP0104760A2 (es)
IL (1) IL143322A0 (es)
NO (1) NO20012947D0 (es)
PL (1) PL348810A1 (es)
WO (1) WO2000035443A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
JP2007063219A (ja) * 2005-09-01 2007-03-15 Juntendo 新生児壊死性腸炎疾患予防剤
ES2875458T3 (es) * 2010-12-29 2021-11-10 Abbott Lab Producto nutricional para uso en la reducción de la incidencia de enterocolitis necrosante en un lactante, niño pequeño o niño
AU2015327027A1 (en) * 2014-09-30 2017-02-23 Société des Produits Nestlé S.A. Nutritional composition for use in promoting gut and/or liver maturation and/or repair
WO2023245470A1 (zh) * 2022-06-22 2023-12-28 南方医科大学珠江医院 Mdp类似物在制备用于治疗炎症性肠病的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
DE3603000A1 (de) * 1986-01-31 1987-08-06 Milupa Ag Neue polyensaeure-reiche fettmischung und deren verwendung bei der herstellung von saeuglingsnahrungen
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
DE4417851C1 (de) * 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use

Also Published As

Publication number Publication date
WO2000035443A1 (en) 2000-06-22
AU3119600A (en) 2000-07-03
EP1140063A1 (en) 2001-10-10
AR021669A1 (es) 2002-07-31
CA2351469A1 (en) 2000-06-22
JP2002532420A (ja) 2002-10-02
PL348810A1 (en) 2002-06-17
WO2000035443A9 (en) 2000-12-07
EA200100662A1 (ru) 2001-12-24
KR20020002361A (ko) 2002-01-09
NO20012947L (no) 2001-06-14
IL143322A0 (en) 2002-04-21
HUP0104760A2 (hu) 2002-04-29
CN1330542A (zh) 2002-01-09
NO20012947D0 (no) 2001-06-14

Similar Documents

Publication Publication Date Title
BR9813474A (pt) Processo para intensificar uma absorção pelo animal de pelo menos um composto lipofìlico, e, composição
BR9809793A (pt) Monoésteres de probucol para o tratamento de doença inflamatória e cardiovascular
ES2195175T3 (es) Preparacion farmaceutica que comprende acido eicosapentaenoico y/o acido estearidonico.
BR9808948A (pt) Composição de confeitaria
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
DE69620291D1 (de) Nahrungszusammensetzungen in verschiedenen Formen
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
DE69409969D1 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
BRPI0412489A (pt) composição de confeito mastigável liberando para as superfìcies dentárias uma dose unitária de uma enzima
PT83143B (pt) Processo para a preparacao de 1,4-dihidro-piridinas 2-substituidas com tiometilo e de composicoes farmaceuticas que as contem
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
PT1216041E (pt) Dieta com elevado teor de lipidos
BR9916156A (pt) Método e composição para a manutenção e restituição de integridade do intestino
BR0214810A (pt) Combinação de um inibidor de il-1/18 com um inibidor de tnf para o tratamento de inflamação
PT965351E (pt) Composicao para alimentos dieteticos e metodo dietetico utilizando este tipo de composicao
BR9912710A (pt) Plantas, sementes e óleos com elavado teor totalde ácidos graxos monoinsaturados
BR9814772A (pt) Composições farmacêuticas sólidas que contêm miltefosina para administração oral no tratamento de leishmaniose
BR9913718A (pt) Processo e composição farmacêutica ou veterinária para inibição profilática ou terapêutica de um material ou substância tóxica em um paciente animal humano ou não-humano, e, uso de um dendrìmero aniÈnico ou catiÈnico
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
PT98816A (pt) Processo para a preparacao de tienodiazepinas e de composicoes farmaceuticas que as contem
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
BR9507495A (pt) Bala para chupar com acão neutralizadora da placa dentária
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
BR9712546A (pt) Adjuvante, notadamente sob a forma de uma emulsão contendo um cátion metálico trivalente e composição vacinal que a compreende
BR9904293A (pt) Composição microbicida tendo pite reduzido para aço inoxidável e processo para reduzir o pite de contenedores de aço inoxidável

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/20 (2006.01), A23C 11/04 (2006.0